Odyssean »

Nuvalent Inc-a shares owned by Odyssean

Quarter-by-quarter ownership of Nuvalent Inc-a (NUVL) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in Nuvalent Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Nuvalent Inc-a held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nuvalent Inc-a by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $287k 2.3k 123.50

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding Nuvalent Inc-a

Deerfield Management Company
FMR
Paradigm Biocapital Advisors
BlackRock
Vanguard Portfolio Management
Wellington Management Company
Vanguard Capital Management
T. Rowe Price Associates
State Street Corporation
Polar Capital Holdings
Goldman Sachs Group
Perceptive Advisors
Deep Track Capital
Geode Capital Management
RA Capital Management

View all funds holding Nuvalent Inc-a